FDA Official Links COVID-19 Vaccines to Pediatric Deaths, Proposes Stricter Approval Standards

An internal memo from the U.S. Food and Drug Administration (FDA) has linked at least 10 child deaths to COVID-19 vaccinations, citing myocarditis—a rare heart inflammation—as a potential cause. The memo, authored by FDA Chief Medical and Scientific Officer Vinay Prasad, describes the findings as "a profound revelation" and signals a shift toward stricter vaccine oversight, including mandatory randomized studies across all subgroups.

The memo does not specify the ages or health conditions of the children, nor does it name the vaccine manufacturers involved. The FDA's review has not yet been published in a peer-reviewed medical journal.

In response to these findings, Health Secretary Robert F. Kennedy Jr. has significantly altered federal COVID-19 vaccine policy by restricting access to individuals aged 65 and older or those with underlying conditions. Kennedy, known for his past criticism of vaccines, has previously linked vaccines to autism and pushed for changes in immunization policy.

The Centers for Disease Control and Prevention's (CDC) vaccine advisory committee is expected to review the findings next week. The FDA is now moving to provide more transparency regarding these findings.

The FDA plans to impose tighter standards for vaccines, particularly those for pregnant women and pneumonia, requiring manufacturers to show effectiveness in preventing disease, not just generating antibodies. While Prasad has been openly critical of the pandemic response, many infectious disease experts continue to defend the safety and life-saving benefits of COVID-19 vaccines, supported by extensive scientific research and controlled studies.